Extract from the Register of European Patents

EP About this file: EP4362966

EP4362966 - GRANZYME-ACTIVATABLE MEMBRANE-INTERACTING PEPTIDES AND METHODS OF USE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.04.2024
Database last updated on 18.03.2026
FormerThe international publication has been made
Status updated on  06.01.2023
Most recent event   Tooltip20.01.2026Amendment by applicant 
Applicant(s)For all designated states
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
1111 Franklin Street, 12th Floor
Oakland, CA 94607-5200 / US
[2024/19]
Inventor(s)01 / CRAIK, Charles S.
San Francisco, California 94143 / US
02 / BARDINE, Conner
San Francisco, California 94158 / US
03 / EVANS, Michael
San Francisco, California 94143 / US
 [2024/19]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[2024/19]
Application number, filing date22834245.730.06.2022
[2024/19]
WO2022US35779
Priority number, dateUS202163216890P30.06.2021         Original published format: US 202163216890 P
[2024/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023278737
Date:05.01.2023
Language:EN
[2023/01]
Type: A1 Application with search report 
No.:EP4362966
Date:08.05.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 05.01.2023 takes the place of the publication of the European patent application.
[2024/19]
Search report(s)International search report - published on:US05.01.2023
(Supplementary) European search report - dispatched on:EP01.07.2025
ClassificationIPC:A61K38/16, A61K47/65, C07K14/00, A61K51/08, A61P29/00, A61P35/00, A61P11/00, C07K14/46, C12Q1/37, G01N33/50
[2025/19]
CPC:
A61K51/088 (EP,US); A61K47/64 (US); A61K47/65 (US);
A61K49/0032 (US); A61K49/0056 (US); A61P11/00 (EP);
A61P29/00 (EP); A61P35/00 (EP); C07K14/001 (EP);
C07K14/463 (EP); C12Q1/37 (EP,US); G01N33/5047 (EP);
C07K2319/00 (EP); G01N2333/96436 (EP) (-)
Former IPC [2024/19]A61K38/16, A61K47/65
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/19]
TitleGerman:GRANZYMAKTIVIERBARE MEMBRANINTERAGIERENDE PEPTIDE UND VERFAHREN ZUR VERWENDUNG[2024/19]
English:GRANZYME-ACTIVATABLE MEMBRANE-INTERACTING PEPTIDES AND METHODS OF USE[2024/19]
French:PEPTIDES INTERAGISSANT AVEC LA MEMBRANE POUVANT ÊTRE ACTIVÉS PAR GRANZYME ET LEURS MÉTHODES D'UTILISATION[2024/19]
Entry into regional phase06.12.2023National basic fee paid 
06.12.2023Search fee paid 
06.12.2023Designation fee(s) paid 
06.12.2023Examination fee paid 
Examination procedure06.12.2023Examination requested  [2024/19]
16.01.2026Amendment by applicant (claims and/or description)
16.01.2026Date on which the examining division has become responsible
Fees paidRenewal fee
27.06.2024Renewal fee patent year 03
28.06.2025Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y] US2016082131  (PAGE MICHAEL et al.) [Y] 1-5,8-15 * paragraphs [0008] , [00 9] , [0 11] , [ 102] , [ 119] * * sequences 1, 18 *
 [Y] US2019010242  (ECKELMAN BRENDAN P et al.) [Y] 1-5,8-15 * paragraphs [0011] , [0 52] , [0 63] *
 [Y] US2021115102  (WINSTON WILLIAM et al.) [Y] 1-5,8-15 * paragraphs [0013] , [0 16] , [ 123] * * table 1 *
 [T]   EVANS MICHAEL ET AL: "Getting a GRIP on antitumor immunity with granzyme targeted PET | Journal of Nuclear Medicine", 1 August 2022 (2022-08-01), XP093263587, Retrieved from the Internet [retrieved on 20250326] [T] * the whole document *
International search[Y] US2016082131  (PAGE MICHAEL et al.) [Y] 1-3, 6-9 * ; especially para [0008]-[0009], [0011], [0102], [0119]; SEQ ID NOs: 1, 18 *
 [Y] US2019010242  (ECKELMAN BRENDAN P et al.) [Y] 1-3, 6-9 * ; especially para [0011], [0052], [0063] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.